<DOC>
	<DOCNO>NCT00004490</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare safety sodium dichloroacetate ( DCA ) v placebo child congenital lactic acidosis . II . Determine quality life patient . III . Determine pharmacokinetics metabolic fate DCA course drug administration patient .</brief_summary>
	<brief_title>Phase III Randomized Study Sodium Dichloroacetate Children With Congenital Lactic Acidosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , crossover study . Patients stratify accord age ( 3 month 2 year vs 2 18 year ) . All patient receive least 12 month sodium dichloroacetate ( DCA ) 2 year period double blind , crossover evaluation DCA placebo mouth . Quality life assess treatment periodically treatment . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Acidosis , Lactic</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis congenital lactic acidosis ( CLA ) meeting follow criterion : Three basal venous lactate least 2.5 mM , arterial lactate least 2.0 mM , CSF lactate least 2.5 mM OR combination , obtain least 1 month within 6 month OR Increase blood lactate least 1.0 mM basal follow carbohydrate meal challenge AND Enzymatic molecular genetic proof defect pyruvate dehydrogenase complex , one respiratory chain enzyme , Krebs cycle enzyme OR Over production C14lactate C14glucose culture skin fibroblast AND Ability withstand 8 hour ( 2 year ) 12 hour ( 2 year ) fast without develop hypoglycemia ( blood glucose less 50 mg/dL ) No secondary lactic acidosis due impaired oxygenation circulation No hyperlactatemia associate proven biotinidase deficiency ( biotin responsive CLA ) enzyme deficiency gluconeogenesis No primary , define organic acidurias lactic acidosis , effective therapy available ( e.g. , propionic aciduria ) No primary disorder amino acid metabolism fatty acid oxidation No malabsorption syndromes associate Dlactic acidosis Prior/Concurrent Therapy No chronic dialysis Patient Characteristics Hepatic : No primary hepatic disease unrelated CLA Renal : Creatinine le 1.2 mg/dL OR Creatinine clearance least 60 mL/min Other : No concurrent infection fever</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2000</verification_date>
	<keyword>disease-related problem/condition</keyword>
	<keyword>inborn error metabolism</keyword>
	<keyword>lactic acidosis</keyword>
	<keyword>quality life</keyword>
	<keyword>rare disease</keyword>
</DOC>